Literature DB >> 8818911

Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci.

K G Van Horn1, C A Gedris, K M Rodney, J B Mitchell.   

Abstract

Brain heart infusion-6-micrograms/ml vancomycin agar plates obtained from five commercial sources (B-D Microbiology Systems, Carr-Scarborough Microbiologicals, MicroBio Products, PML Microbiologicals, and REMEL) were evaluated with 714 enterococci for detection of vancomycin resistance. All 465 (100%) vancomycin-resistant enterococci (MIC > or = 32 micrograms/ml) were detected by each manufacturer's agar screen plate, and each manufacturer's agar screen plate detected at least 99% of the 177 vancomycin-susceptible enterococci (MIC < or = 4 micrograms/ml). Detection of the 72 vancomycin-intermediate enterococci (MIC = 6 to 16 micrograms/ml) ranged from 94% for B-D Microbiology Systems to 99% for PML Microbiologicals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818911      PMCID: PMC229183          DOI: 10.1128/jcm.34.8.2042-2044.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

2.  Species identities of enterococci isolated from clinical specimens.

Authors:  K L Ruoff; L de la Maza; M J Murtagh; J D Spargo; M J Ferraro
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Detection of vancomycin resistance in Enterococcus species.

Authors:  B M Willey; B N Kreiswirth; A E Simor; G Willaims; S R Scriver; A Phillips; D E Low
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

4.  Emergence of vancomycin-resistant enterococci in New York City.

Authors:  T R Frieden; S S Munsiff; D E Low; B M Willey; G Williams; Y Faur; W Eisner; S Warren; B Kreiswirth
Journal:  Lancet       Date:  1993-07-10       Impact factor: 79.321

Review 5.  Antibiotic-resistant enterococci.

Authors:  J W Gray; S J Pedler
Journal:  J Hosp Infect       Date:  1992-05       Impact factor: 3.926

6.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

7.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

8.  New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci.

Authors:  J M Swenson; M J Ferraro; D F Sahm; P Charache; F C Tenover
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

9.  Natural history of colonization with vancomycin-resistant Enterococcus faecium.

Authors:  M A Montecalvo; H de Lencastre; M Carraher; C Gedris; M Chung; K VanHorn; G P Wormser
Journal:  Infect Control Hosp Epidemiol       Date:  1995-12       Impact factor: 3.254

10.  Vancomycin resistance gene vanC is specific to Enterococcus gallinarum.

Authors:  R Leclercq; S Dutka-Malen; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more
  7 in total

1.  Limitations of vitek GPS-418 cards in exact detection of vancomycin-resistant enterococci with the vanB genotype.

Authors:  T Okabe; K Oana; Y Kawakami; M Yamaguchi; Y Takahashi; Y Okimura; T Honda; T Katsuyama
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.

Authors:  P C Kohner; R Patel; J R Uhl; K M Garin; M K Hopkins; L T Wegener; F R Cockerill
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype)

Authors:  B Toye; J Shymanski; M Bobrowska; W Woods; K Ramotar
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.

Authors:  Paul D Stamper; Mian Cai; Clara Lema; Kim Eskey; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2007-08-17       Impact factor: 5.948

5.  Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates.

Authors:  R Patel; K E Piper; M S Rouse; J M Steckelberg; J R Uhl; P Kohner; M K Hopkins; F R Cockerill; B C Kline
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

6.  Evaluation of vancomycin resistance 3 multiplexed PCR assay for detection of vancomycin-resistant enterococci from rectal swabs.

Authors:  Yesim Cekin; Aylin Erman Daloğlu; Dilara Oğünç; Betil Ozhak Baysan; Duygu Dağlar; Dilara Inan; Derya Mutlu; Gözde Ongüt; Dilek Colak
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

7.  Enterococcus casseliflavus Bacteraemia in a Patient with Chronic Renal Disease.

Authors:  Alexandra Vasilakopoulou; Sophia Vourli; Nikolaos Siafakas; Dimitra Kavatha; Nikolaos Tziolos; Spyros Pournaras
Journal:  Infect Dis Rep       Date:  2020-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.